Arginine at position 74 of the HLA-DR β1 chain is associated with Graves' disease

Genes and Immunity

Volumn 5, Issue 3, 2004, Pages 203-208

  Ban, Y ^a   Davies, T F ^a   Greenberg, D A ^b   Concepcion, E S ^a   Osman, R ^a   Oashi, T ^a   Tomer, Yaron ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Association; Autoimmunity; Gene; Graves' disease; HLA

Indexed keywords

ALANINE; ANTITHYROID AGENT; ARGININE; GLYCINE; HLA DR ANTIGEN; RADIOACTIVE IODINE;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENE SEQUENCE; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BINDING; SEQUENCE ANALYSIS; THYROIDECTOMY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; ARGININE; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GRAVES DISEASE; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 3242784051     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6364059     Document Type: Article

References (44)

1. Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997; 84: 223-243.
2. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489-499.
3. Davies TF. Graves' diseases: pathogenesis. In: Braverman LE, Utiger RD, (eds). Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text. Lippincott Williams & Wilkens: Philadelphia, 2000, pp 518-530.
4. Tomer Y, Davies TF. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev 2003; 24: 694-717.
5. Tomer Y, Davies TF. Infection, thyroid disease and autoimmunity. Endocrine Rev 1993; 14: 107-120.
6. Matos-Santos A, Nobre EL, Costa JGE, Nogueira PJ, Macedo A, Galvao-Teles A et al. Relationship between the number and impact of stressful life events and the onset of Graves' disease and toxic nodular goitre. Clin Endocrinol 2003; 55: 15-19.
7. Stenszky V, Kozma L, Balazs C, Rochlitz S, Bear JC, Farid NR. The genetics of Graves' disease: HLA and disease susceptibility. J Clin Endocrinol Metab 1985; 61: 735-740.
8. Mangklabruks A, Cox N, DeGroot LJ. Genetic factors in autoimmune thyroid disease analyzed by restriction fragment length polymorphisms of candidate genes. J Clin Endocrinol Metab 1991; 73: 236-244.
9. Heward JM, Allahabadia A, Daykin J, Carr-Smith J, Daly A, Armitage M et al. Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based study. J Clin Endocrinol Metab 1998; 83: 3394-3397.
10. Yanagawa T, Mangklabruks A, Chang YB, Okamoto Y, Fisfalen M-E, Curran PG et al. Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to Graves' disease in a caucasian population. J Clin Endocrinol Metab 1993; 76: 1569-1574.
11. Ban Y, Davies TF, Greenberg DA, Concepcion ES, Tomer Y. The influence of human leucocyte antigen (HLA) genes on autoimmune thyroid disease (AITD): results of studies in HLA-DR3 positive AITD families. Clin Endocrinol (Oxf) 2002; 57: 81-88.
12. Todd JA, Bell JI, McDevitt HO. HLA-DQbeta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987; 329: 599-604.
13. Winchester R. The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol 1994; 56: 389-466.
14. McDevitt HO. The role of MHC class II molecules in susceptibility and resistance to autoimmunity. Curr Opin Immunol 1998; 10: 677-681.
15. Cucca F, Lampis R, Congia M, Angius E, Nutland S, Bain SC et al. A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. Hum Mol Genet 2001; 10: 2025-2037.
16. Ghosh P, Amaya M, Mellins E, Wiley DC. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 1995; 378: 457-462.
17. Morel PA, Dorman JS, Todd JA, McDevitt HO, Trucco M. Aspartic acid at position 57 of the HLA-DQ beta-chain protects against type I diabetes: a family study. Proc Natl Acad Sci USA 1988; 85: 8111-8115.
18. Doebele RC, Pashine A, Liu W, Zaller DM, Belmares M, Busch R et al. Point mutations in or near the antigen-binding groove of HLA-DR3 implicate class II-associated invariant chain peptide affinity as a constraint on MHC Class II polymorphism. J Immunol 2003; 170: 4683-4692.
19. Chen QY, Huang W, She JX, Baxter F, Volpe R, Maclaren NK. HLA-DRB1*08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves' disease in North American Caucasians, whereas DRB1*07 is protective. J Clin Endocrinol Metab 1999; 84: 3182-3186.
20. Bode HH, Dorf ME, Forbes AP. Familial lymphocytic thyroiditis: analysis of linkage with histocompatibility and blood group. J Clin Endocrinol Metab 1973; 37: 692-697.
21. Roman SH, Greenberg DA, Rubinstein P, Wallenstein S, Davies TF. Genetics of autoimmune thyroid disease: lack of evidence for linkage to HLA within families. J Clin Endocrinol Metab 1992; 74: 496-503.
22. Shields DC, Ratanachaiyavong S, McGregor AM, Collins A, Morton NE. Combined segregation and linkage analysis of Graves' disease with a thyroid autoantibody diathesis. Am J Hum Genet 1994; 55: 540-554.
23. Hawkins BR, Ma JT, Lam KS, Wang CC, Yeung RT. Analysis of linkage between HLA haplotype and susceptibility to Graves' disease in multiple-case Chinese families in Hong Kong. Acta Endocrinol (Copenh) 1985; 110: 66-69.
24. Sakai K, Shirasawa S, Ishikawa N, Ito K, Tamai H, Kuma K et al. Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese. Hum Mol Genet 2001; 10: 1379-1386.
25. Tomer Y, Ban Y, Concepcion E, Barbesino G, Villanueva R, Greenberg DA et al. Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet 2003; 73: 736-747.
26. Ban Y, Greenberg DA, Concepcion ES, Villanueva R, Davies TF, Tomer Y. Is familial Graves' disease (GD) the same as sporadic GD? The 75th Annual Meeting of the American Thyroid Association Florida, September 2003.
27. Schur PH. Genetics of systemic lupus erythematosus. Lupus 1995; 4: 425-437.
28. van der Linden MW, van der Slik AR, Zanelli E, Giphart MJ, Pieterman E, Schreuder GM et al. Six microsatellite markers on the short arm of chromosome 6 in relation to HLA-DR3 and TNF-308A in systemic lupus erythematosus. Genes Immun 2001; 2: 373-380.
29. Lee KH, Wucherpfennig KW, Wiley DC. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat Immunol 2001; 2: 501-507.
30. Sawai Y, DeGroot LJ. Binding of human thyrotropin receptor peptides to a Graves' disease-predisposing human leukocyte antigen class II molecule. J Clin Endocrinol Metab 2000; 85: 1176-1179.
31. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ. CTLA-4 gene polymorphism associated with Graves' disease in a caucasian population. J Clin Endocrinol Metab 1995; 80: 41-45.
32. Vaidya B, Imrie H, Perros P, Young ET, Kelly WF, Carr D et al. The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. Hum Mol Genet 1999; 8: 1195-1199.
33. Ban Y, Davies TF, Greenberg DA, Kissin A, Marder B, Murphy B et al. Analysis of the CTLA-4, CD28 and inducible costimulator (ICOS) genes in autoimmune thyroid disease. Genes Immun 2003; 4: 586-593.
34. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423: 506-511.
35. Tomer Y, Concepcion E, Greenberg DA. A C/T single nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid 2002; 12: 1129-1135.
36. Kim TY, Park YJ, Hwang JK, Song JY, Park KS, Cho BY et al. A C/T polymorphism in the 5′-untranslated region of the CD40 gene is associated with Graves' disease in Koreans. Thyroid 2003; 13: 919-926.
37. Tomer Y, Greenberg DA, Concepcion E, Ban Y, Davies TF. Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases. J Clin Endocrinol Metab 2002; 87: 404-407.
38. Collins JE, Heward JM, Carr-Smith J, Daykin J, Franklyn JA, Gough SCL. Association of a rare thyroglobulin gene microsatellite variant with autoimmune thyroid disease. J Clin Endocrinol Metab 2003; 88: 5039-5042.
39. Ban Y, Greenberg DA, Concepcion E, Skrabanek L, Villanueva R, Tomer Y. Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc Natl Acad Sci USA 2003; 100: 15119-15124.
40. Marsh SG, Bodmer JG, Albert ED, Bodmer WF, Bontrop RE, Dupont B et al. Nomenclature for factors of the HLA system, 2000. Hum Immunol 2001; 62: 419-468.
41. Westman P, Kuismin T, Partanen J, Koskimies S. An HLA-DR typing protocol using group-specific PCR-amplification followed by restriction enzyme digests. Eur J Immunogenet 1993; 20: 103-109.
42. Sorrentino R, Iannicola C, Costanzi S, Ratti G, Hurley C, Tosi R et al. Arg74 in HLA-DRB1 and DRB3 controls a DR3-related epitope. Immunogenetics 1990; 32: 8-12.
43. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955; 19: 251-253.
44. Nicholls A, Honig B. A rapid finite difference algorithm utilizing successive overrelaxation to solve the Poisson-Boltzmann equation. J Comp Chem 1991; 12: 435-445.